Written by Nancy Fliesler
A pair of new studies led by investigators at Harvard Medical School and Boston Children’s Hospital looks to T cells as paths toward reducing organ transplant rejection and treating autoimmune diseases.
The immune system has two major kinds of T cells. T helper cells, also known as effector T cells, tend to rev up our immune responses, while T regulatory cells tend to suppress or downregulate them. Read more.
Share this story
‹ More Featured Studies